OXCARBAZEPINE

OXCARBAZEPINE was reported 15589 times

These side effects are most commonly reported by patients taking OXCARBAZEPINE:

# Side effect Count
0 DRUG INEFFECTIVE 3034
1 SEIZURE 2960
2 OFF LABEL USE 1783
3 FATIGUE 1661
4 DIZZINESS 1574
5 HEADACHE 1479
6 SOMNOLENCE 1477
7 CONVULSION 1465
8 NAUSEA 1356
9 HYPONATRAEMIA 1337
10 FALL 1237
11 VOMITING 1159
12 DRUG INTERACTION 1065
13 RASH 1025
14 ANXIETY 999
15 DEPRESSION 962
16 ASTHENIA 947
17 EPILEPSY 942
18 PAIN 941
19 CONDITION AGGRAVATED 869
20 DIARRHOEA 830
21 INSOMNIA 784
22 WEIGHT INCREASED 784
23 PYREXIA 777
24 DYSPNOEA 768
25 TREMOR 747
26 BALANCE DISORDER 734
27 MALAISE 717
28 MEMORY IMPAIRMENT 717
29 FEELING ABNORMAL 639
30 PRURITUS 632
31 GAIT DISTURBANCE 618
32 CONFUSIONAL STATE 595
33 CONSTIPATION 595
34 WEIGHT DECREASED 592
35 AGGRESSION 562
36 COMPLETED SUICIDE 562
37 PRODUCT USE IN UNAPPROVED INDICATION 554
38 TOXICITY TO VARIOUS AGENTS 549
39 SUICIDAL IDEATION 527
40 OVERDOSE 525
41 DEATH 502
42 PRODUCT DOSE OMISSION ISSUE 497
43 COGNITIVE DISORDER 495
44 PNEUMONIA 481
45 LOSS OF CONSCIOUSNESS 476
46 MATERNAL EXPOSURE DURING PREGNANCY 451
47 HYPOTENSION 442
48 DRUG HYPERSENSITIVITY 423
49 HYPERTENSION 421
50 PAIN IN EXTREMITY 405
51 GENERALISED TONIC-CLONIC SEIZURE 403
52 AGITATION 396
53 ARTHRALGIA 393
54 VISUAL IMPAIRMENT 393
55 DECREASED APPETITE 392
56 URINARY TRACT INFECTION 390
57 NERVOUSNESS 385
58 IRRITABILITY 381
59 COUGH 364
60 SUICIDE ATTEMPT 364
61 ABNORMAL BEHAVIOUR 360
62 ABDOMINAL PAIN 354
63 PRODUCT USE ISSUE 351
64 HYPOAESTHESIA 349
65 VISION BLURRED 349
66 BLOOD SODIUM DECREASED 347
67 HYPERSENSITIVITY 345
68 CHEST PAIN 339
69 STATUS EPILEPTICUS 336
70 SYNCOPE 335
71 FOETAL EXPOSURE DURING PREGNANCY 331
72 PARAESTHESIA 330
73 MULTIPLE-DRUG RESISTANCE 329
74 PRODUCT SUBSTITUTION ISSUE 328
75 DIPLOPIA 324
76 SPEECH DISORDER 320
77 SEDATION 316
78 MUSCLE SPASMS 313
79 FOCAL DYSCOGNITIVE SEIZURES 312
80 ERYTHEMA 304
81 ABDOMINAL PAIN UPPER 299
82 DISORIENTATION 298
83 DYSPHAGIA 298
84 PETIT MAL EPILEPSY 298
85 BACK PAIN 297
86 PARTIAL SEIZURES 294
87 DIABETES MELLITUS 290
88 HALLUCINATION 287
89 DISTURBANCE IN ATTENTION 284
90 ABDOMINAL DISCOMFORT 282
91 PSYCHOTIC DISORDER 278
92 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 275
93 ABORTION SPONTANEOUS 274
94 AMNESIA 268
95 ATAXIA 267
96 GASTROINTESTINAL DISORDER 265
97 HYPERHIDROSIS 257
98 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 256
99 MUSCULAR WEAKNESS 254
100 MIGRAINE 253
101 BLOOD PRESSURE INCREASED 250
102 INTENTIONAL OVERDOSE 248
103 DEPRESSED LEVEL OF CONSCIOUSNESS 247
104 CARDIAC ARREST 246
105 MOVEMENT DISORDER 246
106 CEREBROVASCULAR ACCIDENT 245
107 COMA 245
108 LETHARGY 245
109 MENTAL DISORDER 245
110 TREATMENT FAILURE 241
111 URTICARIA 241
112 SLEEP DISORDER 239
113 DRUG EXPOSURE DURING PREGNANCY 237
114 NASOPHARYNGITIS 237
115 DEHYDRATION 236
116 DYSKINESIA 236
117 DRUG INTOLERANCE 235
118 MYALGIA 233
119 SIMPLE PARTIAL SEIZURES 232
120 STEVENS-JOHNSON SYNDROME 223
121 CONTUSION 221
122 INCORRECT DOSE ADMINISTERED 221
123 ANGER 219
124 DRUG DOSE OMISSION 219
125 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 219
126 DYSARTHRIA 215
127 ALOPECIA 212
128 ANAEMIA 209
129 GRAND MAL CONVULSION 209
130 HOSPITALISATION 209
131 TACHYCARDIA 208
132 CHILLS 207
133 MOBILITY DECREASED 206
134 EXPOSURE DURING PREGNANCY 204
135 MOOD SWINGS 204
136 MULTIPLE SCLEROSIS RELAPSE 204
137 MANIA 203
138 PRODUCT QUALITY ISSUE 202
139 STRESS 202
140 BIPOLAR DISORDER 200
141 DEPRESSED MOOD 200
142 COVID-19 199
143 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 198
144 RENAL FAILURE 193
145 ACUTE KIDNEY INJURY 192
146 PALPITATIONS 190
147 APHASIA 188
148 THROMBOCYTOPENIA 188
149 TREATMENT NONCOMPLIANCE 188
150 CRYING 187
151 MUSCULOSKELETAL STIFFNESS 185
152 RESTLESSNESS 185
153 TYPE 2 DIABETES MELLITUS 185
154 DRUG RESISTANCE 184
155 HEAD INJURY 184
156 NEUROPATHY PERIPHERAL 182
157 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 181
158 VERTIGO 178
159 ALANINE AMINOTRANSFERASE INCREASED 176
160 OEDEMA PERIPHERAL 176
161 INFECTION 173
162 HEART RATE INCREASED 171
163 INJECTION SITE PAIN 170
164 INFLUENZA 169
165 SINUSITIS 169
166 LEUKOPENIA 167
167 MULTIPLE SCLEROSIS 167
168 BLOOD GLUCOSE INCREASED 165
169 CARDIO-RESPIRATORY ARREST 165
170 DRUG ABUSE 162
171 HYPERSOMNIA 161
172 TRIGEMINAL NEURALGIA 160
173 FLUSHING 158
174 DRUG WITHDRAWAL SYNDROME 157
175 WHITE BLOOD CELL COUNT DECREASED 156
176 ELECTROCARDIOGRAM QT PROLONGED 154
177 ILLNESS 152
178 THERAPY NON-RESPONDER 152
179 ADVERSE DRUG REACTION 151
180 BRADYCARDIA 151
181 PANIC ATTACK 147
182 ASPARTATE AMINOTRANSFERASE INCREASED 146
183 ORTHOSTATIC HYPOTENSION 146
184 NEUTROPENIA 144
185 RESPIRATORY FAILURE 144
186 ROAD TRAFFIC ACCIDENT 144
187 UNEVALUABLE EVENT 141
188 BURNING SENSATION 140
189 GASTROOESOPHAGEAL REFLUX DISEASE 140
190 GENERAL PHYSICAL HEALTH DETERIORATION 138
191 SWELLING 138
192 OROPHARYNGEAL PAIN 137
193 SEPSIS 137
194 CHEST DISCOMFORT 136
195 PERIPHERAL SWELLING 136
196 DRY MOUTH 135
197 NO ADVERSE EVENT 135
198 BRONCHITIS 134
199 INFLUENZA LIKE ILLNESS 134
200 INTENTIONAL PRODUCT MISUSE 134
201 PANCREATITIS 134
202 DYSPEPSIA 133
203 HALLUCINATION, AUDITORY 131
204 HEPATIC ENZYME INCREASED 131
205 HYPOKALAEMIA 131
206 MOOD ALTERED 131
207 MYOCARDIAL INFARCTION 131
208 TARDIVE DYSKINESIA 131
209 RESPIRATORY ARREST 130
210 PSYCHOMOTOR HYPERACTIVITY 129
211 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 129
212 COORDINATION ABNORMAL 128
213 BLOOD CHOLESTEROL INCREASED 127
214 OEDEMA 127
215 URINARY INCONTINENCE 127
216 BLISTER 126
217 MENTAL STATUS CHANGES 126
218 RASH MACULO-PAPULAR 126
219 BLOOD CALCIUM DECREASED 125
220 THINKING ABNORMAL 125
221 INJURY 124
222 INTENTIONAL PRODUCT USE ISSUE 123
223 SURGERY 123
224 ABDOMINAL DISTENSION 122
225 ASTHMA 122
226 BLOOD PRESSURE DECREASED 122
227 CHRONIC KIDNEY DISEASE 122
228 DISEASE PROGRESSION 121
229 PRODUCT SUPPLY ISSUE 121
230 SKIN EXFOLIATION 120
231 SLEEP APNOEA SYNDROME 120
232 RHINORRHOEA 119
233 WITHDRAWAL SYNDROME 119
234 ARRHYTHMIA 118
235 NEUROLEPTIC MALIGNANT SYNDROME 118
236 PNEUMONIA ASPIRATION 118
237 DRUG DEPENDENCE 117
238 HYPOTHYROIDISM 117
239 NECK PAIN 117
240 DELIRIUM 116
241 DRY SKIN 116
242 NEURALGIA 116
243 ELECTROENCEPHALOGRAM ABNORMAL 115
244 RASH ERYTHEMATOUS 115
245 DRUG LEVEL DECREASED 114
246 EMOTIONAL DISTRESS 114
247 THERAPEUTIC RESPONSE UNEXPECTED 114
248 UNDERDOSE 114
249 UNRESPONSIVE TO STIMULI 113
250 BLOOD CREATINE PHOSPHOKINASE INCREASED 112
251 OXYGEN SATURATION DECREASED 112
252 HAEMOGLOBIN DECREASED 111
253 PLATELET COUNT DECREASED 111
254 SWELLING FACE 111
255 DRUG ERUPTION 110
256 JOINT SWELLING 110
257 NIGHTMARE 110
258 PRODUCT AVAILABILITY ISSUE 110
259 SEDATION COMPLICATION 110
260 FEAR 109
261 PULMONARY EMBOLISM 109
262 DRUG LEVEL INCREASED 108
263 NEPHROLITHIASIS 108
264 UPPER RESPIRATORY TRACT INFECTION 108
265 BEHAVIOUR DISORDER 107
266 GAMMA-GLUTAMYLTRANSFERASE INCREASED 107
267 CREATININE RENAL CLEARANCE DECREASED 106
268 PARTIAL SEIZURES WITH SECONDARY GENERALISATION 106
269 URINARY RETENTION 106
270 HALLUCINATION, VISUAL 105
271 MUSCLE TWITCHING 105
272 MENTAL IMPAIRMENT 104
273 MEDICATION ERROR 103
274 OSTEOARTHRITIS 103
275 RHABDOMYOLYSIS 103
276 THERAPEUTIC RESPONSE DECREASED 103
277 ADVERSE EVENT 102
278 NYSTAGMUS 102
279 HAEMORRHAGE 101
280 EMOTIONAL DISORDER 100
281 ENCEPHALOPATHY 100
282 PREGNANCY 100
283 CARDIAC DISORDER 99
284 INTESTINAL OBSTRUCTION 99
285 NERVOUS SYSTEM DISORDER 98
286 PHOTOPHOBIA 98
287 POLLAKIURIA 98
288 PREMATURE BABY 98
289 PARANOIA 97
290 DISEASE RECURRENCE 96
291 EATING DISORDER 96
292 PRODUCT DOSE OMISSION 96
293 EPISTAXIS 95
294 INTENTIONAL SELF-INJURY 95
295 ORAL PAIN 95
296 THERAPY CESSATION 95
297 LYMPHADENOPATHY 93
298 ATRIAL FIBRILLATION 92
299 BLOOD CREATININE INCREASED 92
300 RHEUMATOID ARTHRITIS 92
301 HYPOTHERMIA 91
302 BLINDNESS 90
303 HYPERGLYCAEMIA 90
304 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 90
305 DRUG EFFECT DECREASED 89
306 DRY EYE 89
307 DYSURIA 89
308 MYOCLONIC EPILEPSY 89
309 METABOLIC ACIDOSIS 88
310 MYOCLONUS 88
311 RASH PRURITIC 88
312 PRESCRIBED OVERDOSE 87
313 TINNITUS 86
314 DIABETES MELLITUS INADEQUATE CONTROL 85
315 DYSSTASIA 85
316 INCREASED APPETITE 85
317 ABASIA 84
318 DELUSION 84
319 OBESITY 83
320 SKIN DISCOLOURATION 83
321 WHEEZING 83
322 ARTHRITIS 82
323 BLOOD ALKALINE PHOSPHATASE INCREASED 82
324 OSTEOPOROSIS 82
325 WOUND 82
326 AURA 81
327 PSORIASIS 81
328 VIRAL INFECTION 81
329 BLOOD TRIGLYCERIDES INCREASED 79
330 EYE IRRITATION 79
331 SKIN DISORDER 79
332 THROAT IRRITATION 79
333 ANAPHYLACTIC REACTION 78
334 APATHY 78
335 DEVELOPMENTAL DELAY 77
336 DYSGEUSIA 77
337 FLATULENCE 77
338 PANCYTOPENIA 76
339 PLEURAL EFFUSION 76
340 WRONG TECHNIQUE IN DRUG USAGE PROCESS 76
341 DYSTONIA 75
342 ECZEMA 75
343 EYE PAIN 75
344 FEELING HOT 75
345 HYPOTONIA 75
346 RENAL IMPAIRMENT 75
347 THERAPY INTERRUPTED 75
348 WHITE BLOOD CELL COUNT INCREASED 75
349 ACNE 74
350 AFFECTIVE DISORDER 74
351 EAR INFECTION 74
352 FACIAL PAIN 74
353 VISUAL ACUITY REDUCED 74
354 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 73
355 DROOLING 73
356 ACCIDENTAL OVERDOSE 72
357 BRAIN NEOPLASM 72
358 CELLULITIS 72
359 DRUG TOXICITY 72
360 EYE MOVEMENT DISORDER 72
361 ILL-DEFINED DISORDER 72
362 TRANSAMINASES INCREASED 72
363 CAESAREAN SECTION 71
364 CHOLELITHIASIS 71
365 CYANOSIS 71
366 DEMENTIA 71
367 DISCOMFORT 71
368 LIP SWELLING 71
369 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 71
370 RASH GENERALISED 71
371 RENAL DISORDER 71
372 SEPTIC SHOCK 71
373 BLOOD POTASSIUM DECREASED 70
374 COMPLEX PARTIAL SEIZURES 70
375 DYSPHONIA 70
376 INJECTION SITE ERYTHEMA 70
377 LUNG DISORDER 70
378 PANCREATITIS ACUTE 69
379 RENAL FUNCTION TEST ABNORMAL 69
380 EAR PAIN 68
381 HEPATIC FUNCTION ABNORMAL 68
382 HOT FLUSH 68
383 PHARMACEUTICAL PRODUCT COMPLAINT 68
384 RETCHING 68
385 THROMBOSIS 68
386 TOXIC EPIDERMAL NECROLYSIS 68
387 CARDIAC FAILURE 67
388 PRODUCT ADMINISTRATION ERROR 67
389 ABNORMAL DREAMS 66
390 BONE PAIN 66
391 GASTRITIS 66
392 LIMB INJURY 66
393 LIVER DISORDER 66
394 RESPIRATORY TRACT INFECTION 66
395 BRAIN OEDEMA 65
396 CATARACT 65
397 DRUG EFFECT INCOMPLETE 65
398 GASTRIC DISORDER 65
399 NEUROTOXICITY 65
400 RASH MACULAR 65
401 AFFECT LABILITY 64
402 DRUG-INDUCED LIVER INJURY 64
403 HYPERAMMONAEMIC ENCEPHALOPATHY 64
404 LIMB DISCOMFORT 64
405 SEROTONIN SYNDROME 64
406 STOMATITIS 64
407 AGRANULOCYTOSIS 63
408 AKATHISIA 63
409 CHOLESTASIS 63
410 CONJUNCTIVITIS 63
411 HEMIPARESIS 63
412 HERPES ZOSTER 63
413 INTERVERTEBRAL DISC PROTRUSION 63
414 C-REACTIVE PROTEIN INCREASED 62
415 DEEP VEIN THROMBOSIS 62
416 DIABETIC KETOACIDOSIS 62
417 DRUG WITHDRAWAL CONVULSIONS 62
418 EYE DISORDER 62
419 HYPOGLYCAEMIA 62
420 MUSCLE SPASTICITY 62
421 POISONING 62
422 PRODUCT TASTE ABNORMAL 62
423 PSYCHOGENIC SEIZURE 62
424 SCHIZOPHRENIA 62
425 ERECTILE DYSFUNCTION 61
426 EXTRAPYRAMIDAL DISORDER 61
427 SENSORY DISTURBANCE 61
428 LIVER FUNCTION TEST ABNORMAL 60
429 NASAL CONGESTION 60
430 AMMONIA INCREASED 59
431 DRUG ADMINISTRATION ERROR 59
432 FEELING COLD 59
433 FLUID RETENTION 59
434 HYPERAMMONAEMIA 59
435 INFLAMMATION 59
436 MIDDLE INSOMNIA 59
437 OBSESSIVE-COMPULSIVE DISORDER 59
438 BRAIN OPERATION 58
439 DEVICE ISSUE 58
440 DIABETIC NEUROPATHY 58
441 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 58
442 FOOT FRACTURE 58
443 STAPHYLOCOCCAL INFECTION 58
444 CATATONIA 57
445 GRANULOCYTOPENIA 57
446 MULTIPLE DRUG THERAPY 57
447 MUSCLE RIGIDITY 57
448 PARKINSONISM 57
449 TONIC CONVULSION 57
450 HYPERLIPIDAEMIA 56
451 JOINT INJURY 56
452 RENAL FAILURE ACUTE 56
453 RESTLESS LEGS SYNDROME 56
454 SHOCK 56
455 SUDDEN UNEXPLAINED DEATH IN EPILEPSY 56
456 TRANSIENT ISCHAEMIC ATTACK 56
457 DRUG DISPENSING ERROR 55
458 DRUG LEVEL BELOW THERAPEUTIC 55
459 ELECTROLYTE IMBALANCE 55
460 FEELING DRUNK 55
461 HEPATITIS 55
462 HYPOKINESIA 55
463 PRODUCT PHYSICAL ISSUE 55
464 PSYCHOMOTOR RETARDATION 55
465 RESPIRATORY DISORDER 55
466 RESPIRATORY DISTRESS 55
467 SALIVARY HYPERSECRETION 55
468 ALTERED STATE OF CONSCIOUSNESS 54
469 ANTICONVULSANT DRUG LEVEL DECREASED 54
470 APPETITE DISORDER 54
471 ATRIAL SEPTAL DEFECT 54
472 DISABILITY 54
473 GASTROINTESTINAL HAEMORRHAGE 54
474 PRE-EXISTING CONDITION IMPROVED 54
475 SEIZURE CLUSTER 54
476 SWOLLEN TONGUE 54
477 ABORTION INDUCED 53
478 BLOOD GLUCOSE DECREASED 53
479 BRADYKINESIA 53
480 DERMATITIS ALLERGIC 53
481 NEOPLASM MALIGNANT 53
482 PALLOR 53
483 PRODUCT ADMINISTRATION INTERRUPTED 53
484 SCREAMING 53
485 ACTIVITIES OF DAILY LIVING IMPAIRED 52
486 ANOREXIA 52
487 CEREBRAL HAEMORRHAGE 52
488 CHOKING 52
489 HEPATOCELLULAR INJURY 52
490 HYPOPHAGIA 52
491 INTENTIONAL DOSE OMISSION 52
492 PULMONARY OEDEMA 52
493 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 52
494 THIRST 52
495 TOOTHACHE 52
496 CEREBRAL DISORDER 51
497 CREATININE RENAL CLEARANCE INCREASED 51
498 DYSPHORIA 51
499 HEPATIC FAILURE 51
500 INTERSTITIAL LUNG DISEASE 51
501 SYSTEMIC LUPUS ERYTHEMATOSUS 51
502 CARDIAC FAILURE CONGESTIVE 50
503 HEAD DISCOMFORT 50
504 MOTOR DYSFUNCTION 50
505 MOUTH ULCERATION 50
506 MUSCULOSKELETAL PAIN 50
507 RASH PAPULAR 50
508 SNEEZING 50
509 VITAMIN D DEFICIENCY 50
510 CYSTITIS 49
511 HAEMATOCRIT DECREASED 49
512 HEART RATE DECREASED 49
513 HEPATIC STEATOSIS 49
514 OCULAR HYPERAEMIA 49
515 TENDERNESS 49
516 THERAPEUTIC PRODUCT EFFECT DECREASED 49
517 TIC 49
518 ENCEPHALITIS 48
519 GAIT INABILITY 48
520 HYPOXIA 48
521 INJECTION SITE SWELLING 48
522 NORMAL NEWBORN 48
523 POST-TRAUMATIC STRESS DISORDER 48
524 RED BLOOD CELL COUNT DECREASED 48
525 CENTRAL NERVOUS SYSTEM LESION 47
526 CONTRAINDICATED PRODUCT ADMINISTERED 47
527 FIBROMYALGIA 47
528 HAEMATOCHEZIA 47
529 IMPULSIVE BEHAVIOUR 47
530 LEUKOCYTOSIS 47
531 PRODUCT STORAGE ERROR 47
532 PRODUCTIVE COUGH 47
533 SOPOR 47
534 ASPIRATION 46
535 AUTISM SPECTRUM DISORDER 46
536 BLADDER DISORDER 46
537 BODY TEMPERATURE INCREASED 46
538 DEAFNESS 46
539 ENURESIS 46
540 EOSINOPHILIA 46
541 HYPOCHLORAEMIA 46
542 IRRITABLE BOWEL SYNDROME 46
543 NEUTROPHIL COUNT DECREASED 46
544 OSTEOPENIA 46
545 PREMATURE DELIVERY 46
546 TYPE 1 DIABETES MELLITUS 46
547 ANKLE FRACTURE 45
548 HEART RATE IRREGULAR 45
549 IMPAIRED WORK ABILITY 45
550 LIVER INJURY 45
551 PARALYSIS 45
552 POOR QUALITY SLEEP 45
553 PRESCRIBED UNDERDOSE 45
554 SKIN LESION 45
555 DRUG PRESCRIBING ERROR 44
556 FEEDING DISORDER 44
557 FUNGAL INFECTION 44
558 GASTROENTERITIS VIRAL 44
559 GYNAECOMASTIA 44
560 HAEMATURIA 44
561 MUSCLE TIGHTNESS 44
562 POST PROCEDURAL COMPLICATION 44
563 PRURITUS GENERALISED 44
564 RECTAL HAEMORRHAGE 44
565 RIB FRACTURE 44
566 ANGIOEDEMA 43
567 CHROMATURIA 43
568 EUPHORIC MOOD 43
569 INJECTION SITE BRUISING 43
570 VENTRICULAR FIBRILLATION 43
571 ACUTE RESPIRATORY FAILURE 42
572 ANHEDONIA 42
573 ATONIC SEIZURES 42
574 BLOOD CHLORIDE DECREASED 42
575 HUNGER 42
576 IMPAIRED GASTRIC EMPTYING 42
577 INCONTINENCE 42
578 INFANTILE SPASMS 42
579 INJECTION SITE REACTION 42
580 LYMPHOCYTE COUNT DECREASED 42
581 STARING 42
582 VENTRICULAR EXTRASYSTOLES 42
583 ACCIDENT 41
584 ARTHROPATHY 41
585 BLOOD PRESSURE ABNORMAL 41
586 CARPAL TUNNEL SYNDROME 41
587 ECONOMIC PROBLEM 41
588 HAEMATOMA 41
589 INJECTION SITE HAEMORRHAGE 41
590 MYDRIASIS 41
591 POISONING DELIBERATE 41
592 POLYDIPSIA 41
593 VAGINAL HAEMORRHAGE 41
594 VISUAL DISTURBANCE 41
595 BRUXISM 40
596 DYSMORPHISM 40
597 MAJOR DEPRESSION 40
598 PHARYNGITIS 40
599 PROPOFOL INFUSION SYNDROME 40
600 UPPER LIMB FRACTURE 40
601 BIPOLAR I DISORDER 39
602 CIRCULATORY COLLAPSE 39
603 DISSOCIATION 39
604 HYPERKALAEMIA 39
605 HYPOAESTHESIA ORAL 39
606 INJECTION SITE PRURITUS 39
607 LOGORRHOEA 39
608 SCAR 39
609 BEDRIDDEN 38
610 BRAIN FOG 38
611 COLITIS ISCHAEMIC 38
612 DERMATITIS 38
613 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 38
614 GAZE PALSY 38
615 HOMICIDAL IDEATION 38
616 HYPOACUSIS 38
617 IMMUNE THROMBOCYTOPENIA 38
618 INTELLECTUAL DISABILITY 38
619 LIQUID PRODUCT PHYSICAL ISSUE 38
620 LOWER LIMB FRACTURE 38
621 AMENORRHOEA 37
622 ANAL INCONTINENCE 37
623 COLITIS 37
624 DIVERTICULITIS 37
625 DRUG SCREEN POSITIVE 37
626 GASTROENTERITIS 37
627 HAEMATEMESIS 37
628 ORAL DISCOMFORT 37
629 PAIN IN JAW 37
630 PARADOXICAL DRUG REACTION 37
631 PERICARDIAL EFFUSION 37
632 RENAL INJURY 37
633 SENSORY LOSS 37
634 SJOGREN^S SYNDROME 37
635 SKIN WARM 37
636 SOMNAMBULISM 37
637 SPEECH DISORDER DEVELOPMENTAL 37
638 SUDDEN DEATH 37
639 SUSPECTED SUICIDE 37
640 THYROID DISORDER 37
641 ACCIDENTAL EXPOSURE TO PRODUCT 36
642 APNOEA 36
643 COLD SWEAT 36
644 DERMATITIS EXFOLIATIVE 36
645 END STAGE RENAL DISEASE 36
646 EYE SWELLING 36
647 HYPOGAMMAGLOBULINAEMIA 36
648 NO THERAPEUTIC RESPONSE 36
649 PERSONALITY CHANGE 36
650 PSYCHOMOTOR SKILLS IMPAIRED 36
651 STILLBIRTH 36
652 ABDOMINAL PAIN LOWER 35
653 BLOOD BILIRUBIN INCREASED 35
654 BONE MARROW FAILURE 35
655 BREAST CANCER 35
656 CARDIOPULMONARY FAILURE 35
657 DYSPNOEA EXERTIONAL 35
658 ERYTHEMA MULTIFORME 35
659 EXPIRED PRODUCT ADMINISTERED 35
660 GENE MUTATION 35
661 HEPATOMEGALY 35
662 HYPOCALCAEMIA 35
663 INSURANCE ISSUE 35
664 LIBIDO DECREASED 35
665 LOW BIRTH WEIGHT BABY 35
666 MENSTRUATION IRREGULAR 35
667 SKIN BURNING SENSATION 35
668 ATRIOVENTRICULAR BLOCK FIRST DEGREE 34
669 CONCUSSION 34
670 DERMATITIS ATOPIC 34
671 FACE OEDEMA 34
672 FEELING OF DESPAIR 34
673 HYPOMANIA 34
674 METABOLIC DISORDER 34
675 NIGHT SWEATS 34
676 PRODUCT DOSE OMISSION IN ERROR 34
677 SKIN REACTION 34
678 SLEEP DEFICIT 34
679 TOOTH LOSS 34
680 VENTRICULAR TACHYCARDIA 34
681 ARTHRITIS INFECTIVE 33
682 CHANGE IN SEIZURE PRESENTATION 33
683 FEELING JITTERY 33
684 FRACTURE 33
685 GLAUCOMA 33
686 MITOCHONDRIAL DNA MUTATION 33
687 MULTIPLE ORGAN DYSFUNCTION SYNDROME 33
688 PAPULE 33
689 QUALITY OF LIFE DECREASED 33
690 REBOUND EFFECT 33
691 SKIN LACERATION 33
692 SLUGGISHNESS 33
693 SUICIDAL BEHAVIOUR 33
694 WRONG PATIENT RECEIVED PRODUCT 33
695 BLOOD LACTIC ACID INCREASED 32
696 BRADYPHRENIA 32
697 BRAIN INJURY 32
698 CARDIAC MURMUR 32
699 CENTRAL HYPOTHYROIDISM 32
700 CONVERSION DISORDER 32
701 FEMUR FRACTURE 32
702 IMPAIRED QUALITY OF LIFE 32
703 INITIAL INSOMNIA 32
704 INJECTION SITE MASS 32
705 MALIGNANT NEOPLASM PROGRESSION 32
706 PRODUCT COLOUR ISSUE 32
707 PSYCHIATRIC SYMPTOM 32
708 RESPIRATORY RATE INCREASED 32
709 SKIN ULCER 32
710 TOOTH DISORDER 32
711 ANTICONVULSANT DRUG LEVEL INCREASED 31
712 ATRIOVENTRICULAR BLOCK 31
713 CRYPTORCHISM 31
714 DEVICE MALFUNCTION 31
715 HAEMORRHAGIC DIATHESIS 31
716 HIP FRACTURE 31
717 HYPERTHERMIA 31
718 INFUSION RELATED REACTION 31
719 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 31
720 LIVER FUNCTION TEST INCREASED 31
721 PETECHIAE 31
722 PHARYNGEAL OEDEMA 31
723 THERAPY PARTIAL RESPONDER 31
724 ANTINUCLEAR ANTIBODY POSITIVE 30
725 APPLICATION SITE ERYTHEMA 30
726 CROHN^S DISEASE 30
727 HEMIPLEGIA 30
728 IMPAIRED DRIVING ABILITY 30
729 INTENTIONAL DRUG MISUSE 30
730 KIDNEY INFECTION 30
731 MENORRHAGIA 30
732 PHOTOSENSITIVITY REACTION 30
733 PRESYNCOPE 30
734 STRABISMUS 30
735 THROAT TIGHTNESS 30
736 ULCER 30
737 VENTRICULAR SEPTAL DEFECT 30
738 ATTENTION DEFICIT/HYPERACTIVITY DISORDER 29
739 BLOOD GASES ABNORMAL 29
740 BLOOD PRESSURE FLUCTUATION 29
741 BLOOD UREA INCREASED 29
742 CARDIOVASCULAR DISORDER 29
743 CORONARY ARTERY DISEASE 29
744 HALLUCINATIONS, MIXED 29
745 HYPERTONIA 29
746 JAUNDICE 29
747 SELF INJURIOUS BEHAVIOUR 29
748 TEMPERATURE INTOLERANCE 29
749 TORSADE DE POINTES 29
750 CEREBRAL ATROPHY 28
751 DEVICE EXPULSION 28
752 DYSGRAPHIA 28
753 FACE INJURY 28
754 FORMICATION 28
755 GALLBLADDER DISORDER 28
756 JOINT DISLOCATION 28
757 LACRIMATION INCREASED 28
758 LIGAMENT SPRAIN 28
759 PRODUCT PRESCRIBING ERROR 28
760 RECALLED PRODUCT ADMINISTERED 28
761 SCAB 28
762 SINUS DISORDER 28
763 SKIN FISSURES 28
764 SPINAL FRACTURE 28
765 SUBDURAL HAEMATOMA 28
766 TENSION 28
767 TOOTH FRACTURE 28
768 UROSEPSIS 28
769 AUTONOMIC NERVOUS SYSTEM IMBALANCE 27
770 BENIGN PROSTATIC HYPERPLASIA 27
771 BLOOD PROLACTIN INCREASED 27
772 DENTAL CARIES 27
773 ELECTRIC SHOCK SENSATION 27
774 EPILEPTIC ENCEPHALOPATHY 27
775 HIATUS HERNIA 27
776 INTERNATIONAL NORMALISED RATIO INCREASED 27
777 LACERATION 27
778 MATERNAL EXPOSURE BEFORE PREGNANCY 27
779 MULTIPLE DRUG OVERDOSE 27
780 SEASONAL ALLERGY 27
781 SINUS TACHYCARDIA 27
782 ANGINA PECTORIS 26
783 BLOOD PRESSURE SYSTOLIC INCREASED 26
784 CARDIOMEGALY 26
785 GAMBLING DISORDER 26
786 HAEMOPTYSIS 26
787 IMMUNODEFICIENCY 26
788 NEEDLE ISSUE 26
789 OVERWEIGHT 26
790 PANIC DISORDER 26
791 PARAESTHESIA ORAL 26
792 PERSONALITY DISORDER 26
793 PRODUCT ADHESION ISSUE 26
794 RHINITIS 26
795 SEXUAL DYSFUNCTION 26
796 SINUS BRADYCARDIA 26
797 SPINAL OSTEOARTHRITIS 26
798 VENTRICULAR HYPOKINESIA 26
799 VITAMIN D DECREASED 26
800 WRIST FRACTURE 26
801 ACUTE MYOCARDIAL INFARCTION 25
802 BLOOD POTASSIUM INCREASED 25
803 BONE DISORDER 25
804 CONCOMITANT DISEASE AGGRAVATED 25
805 DAYDREAMING 25
806 DECREASED INTEREST 25
807 DEMENTIA ALZHEIMER^S TYPE 25
808 DEVICE DISLOCATION 25
809 DEVICE LEAKAGE 25
810 DYSPHEMIA 25
811 HAEMORRHOIDS 25
812 LEARNING DISORDER 25
813 LENNOX-GASTAUT SYNDROME 25
814 MITRAL VALVE INCOMPETENCE 25
815 MOUTH HAEMORRHAGE 25
816 MULTI-ORGAN FAILURE 25
817 MUSCLE CONTRACTIONS INVOLUNTARY 25
818 PARKINSON^S DISEASE 25
819 PRODUCT USE COMPLAINT 25
820 REFUSAL OF TREATMENT BY PATIENT 25
821 RENAL CYST 25
822 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 25
823 SELF-INJURIOUS IDEATION 25
824 SPINAL PAIN 25
825 TACHYPNOEA 25
826 TUBULOINTERSTITIAL NEPHRITIS 25
827 VISUAL FIELD DEFECT 25
828 ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC 24
829 ATTENTION DEFICIT HYPERACTIVITY DISORDER 24
830 CARDIOGENIC SHOCK 24
831 CARDIOMYOPATHY 24
832 CLUMSINESS 24
833 COVID-19 PNEUMONIA 24
834 DECREASED ACTIVITY 24
835 DEPRESSIVE SYMPTOM 24
836 DIABETIC COMA 24
837 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 24
838 EDUCATIONAL PROBLEM 24
839 ELECTROCARDIOGRAM ABNORMAL 24
840 ENERGY INCREASED 24
841 EOSINOPHIL COUNT INCREASED 24
842 EXTRA DOSE ADMINISTERED 24
843 HAND FRACTURE 24
844 HYPERTENSIVE CRISIS 24
845 IMMUNOSUPPRESSION 24
846 LOCAL SWELLING 24
847 LYMPHOPENIA 24
848 NEONATAL RESPIRATORY DISTRESS SYNDROME 24
849 NEUTROPHIL COUNT INCREASED 24
850 PERIPHERAL COLDNESS 24
851 POSTICTAL STATE 24
852 PROTHROMBIN TIME PROLONGED 24
853 SCRATCH 24
854 TERMINAL INSOMNIA 24
855 TOXIC ENCEPHALOPATHY 24
856 TRICUSPID VALVE INCOMPETENCE 24
857 AUTISM 23
858 BUNDLE BRANCH BLOCK RIGHT 23
859 COMMUNICATION DISORDER 23
860 FOOD ALLERGY 23
861 HEPATITIS C 23
862 HYPERAESTHESIA 23
863 HYPERNATRAEMIA 23
864 MALNUTRITION 23
865 MICTURITION URGENCY 23
866 MUSCULOSKELETAL CHEST PAIN 23
867 POTENTIATING DRUG INTERACTION 23
868 RESPIRATORY DEPRESSION 23
869 SCHIZOAFFECTIVE DISORDER 23
870 SKIN IRRITATION 23
871 THERAPEUTIC RESPONSE SHORTENED 23
872 TONGUE BITING 23
873 TOOTH EXTRACTION 23
874 APPLICATION SITE PAIN 22
875 ATELECTASIS 22
876 BACK INJURY 22
877 CARDIOTOXICITY 22
878 CLOSTRIDIUM DIFFICILE INFECTION 22
879 CYTOLYTIC HEPATITIS 22
880 DERMATITIS BULLOUS 22
881 DERMATITIS CONTACT 22
882 GALACTORRHOEA 22
883 HERNIA 22
884 IMPAIRED HEALING 22
885 INABILITY TO AFFORD MEDICATION 22
886 IRON DEFICIENCY ANAEMIA 22
887 LOCALISED INFECTION 22
888 MASS 22
889 MUSCULOSKELETAL DISORDER 22
890 ORAL HERPES 22
891 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 22
892 PULMONARY HYPERTENSION 22
893 SCOLIOSIS 22
894 SMALL FOR DATES BABY 22
895 SOCIAL AVOIDANT BEHAVIOUR 22
896 THERAPY CHANGE 22
897 AGEUSIA 21
898 BLOOD DISORDER 21
899 BLOOD TEST ABNORMAL 21
900 CEREBELLAR ATROPHY 21
901 COLITIS ULCERATIVE 21
902 CYST 21
903 DEVICE RELATED INFECTION 21
904 DIFFICULTY IN WALKING 21
905 ENCEPHALITIS AUTOIMMUNE 21
906 EXCESSIVE EYE BLINKING 21
907 FEBRILE NEUTROPENIA 21
908 GASTRIC ULCER 21
909 GLUCOSE TOLERANCE IMPAIRED 21
910 GUN SHOT WOUND 21
911 HYPERTRANSAMINASAEMIA 21
912 HYPOMAGNESAEMIA 21
913 ISCHAEMIC STROKE 21
914 JOINT STIFFNESS 21
915 LABORATORY TEST ABNORMAL 21
916 LACTIC ACIDOSIS 21
917 LIPASE INCREASED 21
918 MATERNAL DRUGS AFFECTING FOETUS 21
919 MENINGITIS 21
920 MYOCARDITIS 21
921 NERVE INJURY 21
922 PLEOCYTOSIS 21
923 POSTICTAL PARALYSIS 21
924 PRODUCT ODOUR ABNORMAL 21
925 PROTEINURIA 21
926 PULMONARY MASS 21
927 RASH VESICULAR 21
928 ROTATOR CUFF SYNDROME 21
929 SKIN HAEMORRHAGE 21
930 SLEEP PARALYSIS 21
931 STOMACH DISCOMFORT 21
932 TASTE DISORDER 21
933 TEMPORAL LOBE EPILEPSY 21
934 TRISOMY 21 21
935 URINARY TRACT DISORDER 21
936 WRONG DRUG ADMINISTERED 21
937 ACUTE RESPIRATORY DISTRESS SYNDROME 20
938 APLASTIC ANAEMIA 20
939 BLOOD GLUCOSE ABNORMAL 20
940 BONE DENSITY DECREASED 20
941 BRADYPNOEA 20
942 BUNDLE BRANCH BLOCK LEFT 20
943 CEREBRAL INFARCTION 20
944 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 20
945 COMPLICATION ASSOCIATED WITH DEVICE 20
946 CONGENITAL HYDRONEPHROSIS 20
947 CSF OLIGOCLONAL BAND PRESENT 20
948 DECUBITUS ULCER 20
949 DEVELOPMENTAL HIP DYSPLASIA 20
950 GENERAL PHYSICAL CONDITION ABNORMAL 20
951 GENERALISED ERYTHEMA 20
952 GLOSSODYNIA 20
953 GLYCOSYLATED HAEMOGLOBIN INCREASED 20
954 HEPATOTOXICITY 20
955 HYDRONEPHROSIS 20
956 HYPERBILIRUBINAEMIA 20
957 HYPERPROLACTINAEMIA 20
958 INFUSION SITE ERYTHEMA 20
959 INJECTION SITE RASH 20
960 INTERVERTEBRAL DISC DEGENERATION 20
961 MUSCLE DISORDER 20
962 NEOPLASM 20
963 PIGMENTATION DISORDER 20
964 POLYURIA 20
965 PRE-ECLAMPSIA 20
966 PROCEDURAL PAIN 20
967 PSYCHOTIC SYMPTOM 20
968 STREPTOCOCCAL INFECTION 20
969 THERAPEUTIC PRODUCT CROSS-REACTIVITY 20
970 TONSILLITIS 20
971 ACUTE HEPATIC FAILURE 19
972 ADVERSE REACTION 19
973 ANURIA 19
974 APHTHOUS ULCER 19
975 BACTERIAL INFECTION 19
976 COAGULOPATHY 19
977 CONDUCTION DISORDER 19
978 DEVICE BREAKAGE 19
979 DIZZINESS POSTURAL 19
980 DRUG DOSE OMISSION BY DEVICE 19
981 DRUG EFFECT LESS THAN EXPECTED 19
982 DRUG LEVEL ABOVE THERAPEUTIC 19
983 DRUG TOLERANCE 19
984 EYE PRURITUS 19
985 EYELID OEDEMA 19
986 EYELID PTOSIS 19
987 FACIAL PARALYSIS 19
988 FAECES DISCOLOURED 19
989 FOOT DEFORMITY 19
990 GRIP STRENGTH DECREASED 19
991 GROWTH RETARDATION 19
992 HAEMATOLOGICAL INFECTION 19
993 HAEMODYNAMIC INSTABILITY 19
994 HAEMORRHAGE INTRACRANIAL 19
995 HYPOTONIA NEONATAL 19
996 INCOHERENT 19
997 INCREASED TENDENCY TO BRUISE 19
998 MENISCUS INJURY 19
999 METRORRHAGIA 19